The treatment of advanced colorectal cancer with interferon-α: a review

Bibliography

• HILL M, NORMAN A, CUNNINGHAM D et al.:Impactofprotracted venous infusion at fluorouracil with or without interferon alpha- 2b on tumour response, su-vival and quality of life in advanced colorectal cancer. j Gun. Oncol.(1995) 13:2317–2323.
   Web of Science ®Google Scholar
• THE ADVANCED COLORECTAL CANCER META-ANALYSISPROJECT: Modulationoffluorouracilbyleucovorininpatientswithadvancedcolorectalcancer.J. Clin. Oncol(1992) 10:896–903.
   PubMed Web of Science ®Google Scholar
• THE ADVANCED COLORECTAL CANCER META-ANALYSIS PROJECT: Meta-analysisofrandomisedtrialstestingthe biochemical modulation of fluorouracil by methotrexateinmetastaticcolorectalcancer.J. Clin. Oncol.(1994) 12:960–969.
   PubMed Web of Science ®Google Scholar
• ROSENBERG SA: Principlesofcancermanagement:bio-logicaltherapy.In: Cancer: Principles and Practice of On-cology.De Vita VT Jr., Hellman S, Rosenberg SA (Eds.), JP Lippincott, Philadelphia, PA (1997)349–373.
   Google Scholar
• WADLER S, WERSTO R, WEINBERG V et al:Interactionoffluorouracil and interferon in human colon cancer celllines:cytotoxicandcytokineticeffects.Cancer Res.(1990) 50:5735–5739.
   PubMed Web of Science ®Google Scholar
• ELIAS L, SANDOVAL JM: Interferoneffectsuponfluor-ouracilmetabolismbyHL-60cells.Biochem. Biophys. Res. Commun.(1989) 163:867–874.
   PubMed Web of Science ®Google Scholar
• SCHWARTZ EL, HOFFMAN M, O'CONNOR CJ et al:Stimu-lation of 5-FU metabolic activation by interferon-a in humancoloncarcinomacells.Biochem. Biophys. Res. Commun.(1992) 182:1232–1239.
   PubMed Web of Science ®Google Scholar
• SCHWARTZ EL, BAPISTE N, O'CONNOR CJ et al:Potentia-tion of the anitumour activity of 5-FU in colon carci-noma cells by combination of interferon and deoxyribonucleosides results in complementary ef-fectsonthymidinephosphorylase.Cancer Res.(1994) 54:1472–1458.
   PubMed Web of Science ®Google Scholar
• GREM JL, MCATEE N, MURPHY RF et al.:Apilotstudyofinterferon alpha-2a in combination with fluorouracil plus high-dose leucovorin in metastatic gastrointesti-nalcarcinoma.J. Clin. Oncol.(1991) 9:1811–1820.
   Google Scholar
• YEE LK, ALLEGRA CJ, STEINBERG SM et al.:Decreasedca-tabolism of fluorouracil in peripheral blood mononu-clear cells during combination therapy with fluorouracil,leucovorinandinterferona-2a.J. Natl. Cancer Inst.(1992) 84:1820–1825.
   Google Scholar
• HOUGHTON JA, MORTON CL, ADKINS DA et al.:Locusof interaction amoung 5-fluorouracil, lecovorin, and in-terferon-aincoloncarcinomacells.Cancer Res.(1993) 53:4243–4250.
   PubMed Web of Science ®Google Scholar
• CHU E, ZINN S, BOARMAN D et al.:Interactionofinter-feron and 5-flourouracil in 11630 human coloncarci-nomacellline.Cancer Res.(1990) 50:5834–5840.
   PubMed Web of Science ®Google Scholar
• WADLER S, SCWARTZ EL: Antineoplasticactivityofthecombination of interferon and cytotoxic agents against experimental and human malignancies: a re-view.Cancer Res.(1990) 50:3473–3486.
   PubMed Web of Science ®Google Scholar
• WADLER S, SCHWARTZ EL, GOLDMAN M et al.:Fluorou-racil and recombinant alfa-2a-interferon: an active regimenagainstadvancedcolorectalcarcinoma.J. Clin. Oncol.(1989) 7:1769–1775.
   Google Scholar
• WADLER S, WIERNIK PH: Clinicalupdateontheroleoffluorouracil and recombinant alpha-2a-interferon in thetreatmentofcolorectalcarcinoma.Semin. Oncol.(1990) 17:16–21.
   PubMed Web of Science ®Google Scholar
• WADLER S, LEMBERSKY B, ATKINS M et al.:PhaseIItrialof fluorouracil and recombinant interferon alpha-2a in patients with advanced colorectal carcinoma: an EasternCooperativeOncologyGroupstudy.J. Clin. On-col.(1991) 9:1806–1810.
   Google Scholar
• PAZDUR R, AJANI JA, YEHUDA Z et al.:PhaseIIstudyoffluorouracil and recombinant interferon alfa-2a in previously untreated advanced colorectal carcinoma. Clin. Oncol(1990) 8:2027–2031.
   Web of Science ®Google Scholar
• KEMENY N, YOUNES A, SETTER K et al.:Interferonalpha-2a and 5-fluorouracil for advanced colorectal carcinoma.Assessmentofactivityandtoxicity.Cancer(1990) 66:2470–2475.
   Google Scholar
• WEH HJ, PLATZ D, BRAUMANN D et al:PhaseIItrialoffluorouracil and recominant interferon alpha-2B in metastasticcolorectalcarcinoma.Eur. J. Cancer(1992) 28A:1820–1823.
   PubMed Web of Science ®Google Scholar
• POON MA, O'CONNELL MJ, MOERTAL CG et al.:Bio-chemical modulation of fluorouracil. Evidence of sig-nificant improvement of survival and quality of life in patientswithadvancedcolorectalcarcinoma.J. Clin. Oncol.(1989) 7:1407–1417.
   Google Scholar
• BUKOWSKI RM, INOSHITA G, YALAVARTHI P et al.:APhase I trial of 5-fluorouracil, folinic acid and alpha-2a-interferon in patients with metastatic colorectal carcinoma.Cancer(1992) 69:889–892.
   PubMed Web of Science ®Google Scholar
• PUNT CJ, BURGOUTS JT, CROLES JJ eta].:Continuousin-fusion of high dose 5-fluorouracil in combination with leucovorin and recombinant interferon-alpha-2b in patients with advanced colorectal cancer. A multicen-trePhaseIIstudy.Cancer(1993) 72:2107–2111.
   Google Scholar
• CASCINU S, FEDELI A, FEDELI SL et al:Doublebiochemi-cal modulation of 5-fluorouracil by leucovorin and cy-clic low dose interferon alpha 2b in advanced cancer patients.Ann. Oncol(1992) 3:489–491.
   PubMed Web of Science ®Google Scholar
• GREM JL, JORDAN E, ROBSON ME et al:PhaseIIstudyoffluorouracil, leucovorin and interferon alpha-2a in metastaticcolorectalcarcinoma.J. Clin. Oncol(1993) 11:1737–1745.
   PubMed Web of Science ®Google Scholar
• LABIANCA R, GIACCON G, BARNI S et al.:Doublemodu-lation of 5-fluorouracil in advanced colorectal cancer with low dose interferon-alpha 2b and folinic acid. The "Giscad" experience. Italian Group for the Study of DigestiveTractCancer.Eur. J. Cancer(1994) 30A:1611–1616 .
   Google Scholar
• MOORE MJ, KAIZER L, ERLICHMAN C et al:Aclinicalandpharmacological study of 5-fluorouracil, leucovorin and interferon alpha in advanced colorectal cancer. Cancer Chemother. & Pharmacol(1995) 37:86–90.
   PubMed Web of Science ®Google Scholar
• KOHNE CH, WILKE H, HIDDEMANN W et alPhaseII evaluation of 5-fluorouracil plus folinic acid and alpha 2b-interferoninmetastaiccolorectalcancer.Oncology(1997) 54:96–101.
   PubMed Web of Science ®Google Scholar
• KOSMIDIS PA, TSAVARIS N, SKARLOS D et al:Fluoroura-cil and leucovorin with or without interferon alpha-2b in advanced colorectal cancer: analysis of a prospec-tiverandomisedPhaseIIItrial.J. Clin. Oncol.(1996) 14:2682–2687.
   PubMed Web of Science ®Google Scholar
• GRECO FA, FIGLIN R, YORK M et al.:PhaseIIIrandom-ised study to compare interferon alpha-2a in combina-tion with fluorouracil versus fluorouracil alone in patientswithadvancedcolorectalcancer.J. Clin. Oncol(1996) 14:2671–2681.
   Google Scholar
• SEYMOUR MT, SLEVIN ML, KARR DJ eta].:Randomisedtrial assessing the addition of interferon a-2a to fluor-ouracil and leucovorin in advanced colorectal cancer. Clin. Oncol.(1996) 14:2280–2288.
   Google Scholar
• CORFU-A STUDY GROUP: PhaseIIIrandomisedstudyoftwo fluorouracil combinations with either interferon alpha-2a or leucovorin for advanced colorectal cancer. Clin. Oncol.(1995) 13:921–928.
   Web of Science ®Google Scholar
• HILL M, NORMAN A, CUNNINGHAM D et al:RoyalMars-den Phase III trial of fluorouracil with or without inter-feronalpha-2binadvancedcolorectalcancer.J. Clin. Oncol.(1995)13:1297–1302.
   PubMed Web of Science ®Google Scholar
• DUFOUR P, HUSSEINE F, DREYFUS B et al.:5-Fluorouracil versus 5-fluorouracil plus alpha-interferon as treatment of metastastic colorectal carci-noma.Arandomisedstudy.Ann. Oncol.(1996) 7:575–579.
   Google Scholar
• RECCHIA F, NUZZO A, LALLI A et al:Randomisedtrialof5-fluorouracil and high dose folinic acid with or with-out alpha-2b interferon in advanced colorectal cancer. Am. J. Clin. Oncol.(1996) 19:301–304.
   PubMed Web of Science ®Google Scholar
• KOHNE C-H, SCHOFFSKI P, WILKE H et al:Effectivebio-modulation by leucovorin of high dose infusion fluor-ouracil given as a weekly 24-hour infusion: results of a randomised trial in patients with advanced colorectal cancer.J. Clin. Oncol.(1998) 16:418–426.
   PubMed Web of Science ®Google Scholar
• LOKICH JJ, AHLGREN JD, GULLO JJ et al.:Aprospectiverandomised comparison of continuous infusion fluor-ouracil with a conventional bolus schedule in meta-static colorectal carcinoma: a Mid-Atlantic Oncology ProgramStudy.J. Clin. Oncol.(1989) 7:425-432. © Ashley Publications Ltd. All rights reserved.Exp. Opin. Invest. Drugs(1999) 8(1)
   Google Scholar
• HILL M, NORMAN, CUNNINGHAM D et al.:Impactofpro- tracted venous infusion flurouracil with or without in-terferon alpha- 2b on tumour response, survival and quantityoflifeinadvancedcolorectalcancer.J. Clin. Oncol.(1995) 13:2317–2323.
   Google Scholar